Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
about
Pre-hospital treatment of acute poisonings in Oslo.Fatal poisonings in Oslo: a one-year observational study.Suicidal intention, psychosocial factors and referral to further treatment: a one-year cross-sectional study of self-poisoningCircumstances surrounding non-fatal opioid overdoses attended by ambulance servicesOverdose prevention and naloxone prescription for opioid users in San FranciscoRisk factors for nonfatal overdose at Seattle-area syringe exchanges.Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Outpatient treatment of acute poisonings in Oslo: poisoning pattern, factors associated with hospitalization, and mortality.Attitudes and knowledge about naloxone and overdose prevention among detained drug users in Ningbo, China.Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. cityDistribution of naloxone for overdose prevention to chronic pain patients.A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelaeReversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case SeriesA response to the opioid overdose epidemic: naloxone nasal sprayEMS runs for suspected opioid overdose: implications for surveillance and prevention.Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users.OxyContin abuse and overdose.No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose.Adult cyclical vomiting syndrome: a disorder of allostatic regulation?International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope database.Do heroin overdose patients require observation after receiving naloxone?Incorporation of poison center services in a state-wide overdose education and naloxone distribution program.Validation of Criteria to Guide Prehospital Naloxone Administration for Drug-Related Altered Mental StatusNaloxone--does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose.Surveying the opinions of Pennsylvania Chiefs of Police toward officers carrying and administering naloxone.The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical SpecialtyExpanding access to naloxone in the United States.Clinical cases in acute intoxication.Tramadol overdose as a cause of serotonin syndrome: a case series.Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study.Acute poisonings treated in hospitals in Oslo: a one-year prospective study (II): clinical outcome.Acute poisonings treated in hospitals in Oslo: a one-year prospective study (I): pattern of poisoning.Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat.Naloxone use in a tiered-response emergency medical services system.Naloxone dosage for opioid reversal: current evidence and clinical implications.Pre-hospital management and outcome of acute poisonings by ambulances in Yekaterinburg, Russia.
P2860
Q33386238-EF0C409C-B0DF-4594-83E7-F3BD132E1418Q33595413-A771563D-4031-470D-A73A-07172297B586Q33639058-42E4341A-68A9-4E12-883A-3A80BEF7EADCQ33697978-EAD78AF9-4FE3-4424-8806-8E6FCD22970AQ34420178-DFDBA97C-FD76-4603-8F37-ACA6211B0299Q34588009-5A49777D-C2B4-42B1-996F-970CA87541ECQ35019475-09F4A23B-7A91-4D79-A80B-5DAEB7FAB621Q35183142-9D5E5F15-DFCF-4FB6-BDAA-3D4017A169BCQ35751870-D90D5155-29DE-4F5E-A363-B899825B24E8Q35773083-54E26462-477A-4D40-89C9-BE1D32F11300Q35808935-2E088C97-3C02-41B2-9142-EFCE891F775EQ35946118-84C4781F-F231-4A30-8E1D-122DD368E523Q36117657-7FA0D44E-3D14-4F60-AE30-0F15B3BDCE32Q36146325-389B013A-2B14-45F6-BCED-FCAD8015FF0DQ36660823-015901BD-51A0-42F0-A895-666851E47097Q36890018-68234F53-EF83-4078-B363-F08F237AD948Q36929678-59B5BFE4-BF5F-4325-B0E3-FFE30F287DE9Q37389637-53A9D754-0A81-48D4-B929-2DC7D38E21F3Q37394665-4394C635-572A-4F63-B0B1-A7CACF7C591CQ37427260-E79568C4-9F60-4CDB-BC33-0194C3CC9DFFQ37879686-04292501-9FED-49F7-80ED-C81F5C626234Q38204901-13F59885-E2AE-46FC-AD67-4D306433260FQ38734821-779DD040-22F5-49C9-8BF9-54D71C396D87Q39010022-46AAE01D-75C6-4418-8591-193D1FFE609AQ39740001-EA865405-A916-47A1-AD8B-DD47CC228B2AQ39847206-F9890B1D-9EB4-46F0-A05C-CF2722676CBAQ40292190-0C254C3F-6573-4762-A67B-9B71F8614BE8Q40482620-495A38A4-4F90-4730-943B-046CF2418FC7Q41240281-7EB1F1D0-09FB-4B1C-AFCE-8D321F8C0FAFQ41982971-C8EB63B8-D650-4BFA-A53E-BFA10B1E275EQ42874561-62A379A9-A8C8-4DE6-8507-854669436B8BQ43109577-83F101A3-3A76-4571-9E5F-7ED8F180EB60Q44344344-1A63579A-BB84-47F7-9459-A76C5860C436Q44350979-ACCAEBBD-A268-4AA5-AD79-EDC7A0C4433AQ46827064-9AD41E53-4767-4738-A14D-EBDF00D1A766Q46827071-67AF4BA2-D18D-4EE3-92D0-A1EADA2BE6C2Q47705786-115D26FC-58B8-41EA-9A12-BD21982A0136Q47848315-F75F4D28-5447-41AC-824F-ABEAD0CDA41DQ48275689-0ECCC4C6-1AAD-42C0-B6F1-925636EB8E2DQ48438517-D1B79CF7-4085-4FDC-ACC1-0A406111F064
P2860
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
@en
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
@nl
type
label
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
@en
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
@nl
prefLabel
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
@en
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
@nl
P2093
P1476
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
@en
P2093
Anne-Cathrine Naess
Dag Jacobsen
Ingebjørg Buajordet
P356
10.1097/00063110-200402000-00004
P577
2004-02-01T00:00:00Z